Postprandial hyperglycemia
2 papers
- Human trial2
Trial sponsors
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
1 trialPhase 421 people
1 trialPhase 322 people
Washington University School of Medicine
1 trialPhase 1/21 person
1 trialPhase 115 people
Latest
2 in 12 monthsADA Scientific Sessions 2026 Abstract
Semaglutide Improves Postprandial Glucose Metabolism after Spinal Cord Injury: A First Mechanistic Study
Non-randomised trial in 5 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Effects of Lowering Carbohydrate Amount and Glycemic Index on Whole-Body and Organ-Specific Aging Proteins and Postprandial Glucose Metabolism: The OmniCarb Trial
Randomised trial in 48 peopleInterventions
Cardiovascular Diabetology
Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study
Randomised trial in 30 peopleType 2 diabetes
The Journal of Clinical Endocrinology and Metabolism
Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study
Randomised trial in 14 peopleInterventions
Diabetes Care
A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
Randomised trial in 1,946 peopleType 2 diabetes
Diabetes Care
Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone
Randomised trial in 94 peopleInterventions